66 related articles for article (PubMed ID: 28447402)
1. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
Bodakçi E
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
[TBL] [Abstract][Full Text] [Related]
2. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-Occurring Autoimmunity?
Birnbaum J; Atri NM; Baer AN; Cimbro R; Montagne J; Casciola-Rosen L
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1069-1075. PubMed ID: 27696784
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
5. Disease Duration Affects the Clinical Phenotype of Primary Sjögren Syndrome: A Medical Records Review Study of 952 Cases.
Zhang Y; Yang JY; Chen JQ; Liao JH; Huang ZW; Wu TH; He Q; Yu XB; Wang Q; Song WJ; Luo J; Tao QW
J Clin Rheumatol; 2024 Jun; 30(4):151-158. PubMed ID: 38389137
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Sjögren's syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases.
Narváez J; Sánchez-Fernández SÁ; Seoane-Mato D; Díaz-González F; Bustabad S
Sci Rep; 2020 Jun; 10(1):10627. PubMed ID: 32606345
[TBL] [Abstract][Full Text] [Related]
7. Positive anti-nuclear antibody in patients with polyclonal hypergammaglobulinemia suggests the presence of multiple distinct comorbidities.
Masuda Y; Morita K; Kurokawa M
Intern Med; 2024 May; ():. PubMed ID: 38692914
[TBL] [Abstract][Full Text] [Related]
8. Sjogren's syndrome from the perspective of ophthalmology.
Kuklinski E; Asbell PA
Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
[TBL] [Abstract][Full Text] [Related]
9. Clinical Profile of Patients with Primary Sjögren's Syndrome with Non-Identified Antinuclear Autoantibodies.
Parisis D; Sarrand J; Cabrol X; Delporte C; Soyfoo MS
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732349
[TBL] [Abstract][Full Text] [Related]
10. The Spectrum of Extraglandular Manifestations in Primary Sjögren's Syndrome.
Mihai A; Caruntu C; Jurcut C; Blajut FC; Casian M; Opris-Belinski D; Ionescu R; Caruntu A
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373950
[TBL] [Abstract][Full Text] [Related]
11. Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome.
Lin W; Xin Z; Wang J; Ren X; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Liu M; Su Y; Sun L; Zhang F; Zhang W
Clin Rheumatol; 2022 Jul; 41(7):2091-2102. PubMed ID: 35348930
[TBL] [Abstract][Full Text] [Related]
12. Discordant Predictions of Extraglandular Involvement in Primary Sjögren's Syndrome According to the Anti-SSA/Ro60 Antibodies Detection Assay in a Cohort Study.
Urbanski G; Gury A; Jeannin P; Chevailler A; Lozac'h P; Reynier P; Lavigne C; Lacout C; Vinatier E
J Clin Med; 2022 Jan; 11(1):. PubMed ID: 35011983
[TBL] [Abstract][Full Text] [Related]
13. Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway.
de Oliveira FR; Fantucci MZ; Adriano L; Valim V; Cunha TM; Louzada-Junior P; Rocha EM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544839
[TBL] [Abstract][Full Text] [Related]
14. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
Ter Borg EJ; Kelder JC
Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
[TBL] [Abstract][Full Text] [Related]
15. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
Nardi N; Brito-Zerón P; Ramos-Casals M; Aguiló S; Cervera R; Ingelmo M; Font J
Clin Rheumatol; 2006 May; 25(3):341-6. PubMed ID: 16249826
[TBL] [Abstract][Full Text] [Related]
16. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
17. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
18. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
